Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Peptic Ulcer

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 52 articles:
HTML format
Text format



Single Articles


    July 2018
  1. CHUANG SC, Lin CC, Peng CY, Huang WH, et al
    Proton pump inhibitors increase the risk of cholecystitis: a population-based case-control study.
    Gut. 2018 Jul 17. pii: gutjnl-2018-316899. doi: 10.1136/gutjnl-2018-316899.
    PubMed     Text format    


  2. MOAYYEDI P, Veldhuyzen van Zanten SJO, Hookey L, Armstrong D, et al
    Proton pump inhibitors and gastric cancer: association is not causation.
    Gut. 2018 Jul 13. pii: gutjnl-2018-316958. doi: 10.1136/gutjnl-2018-316958.
    PubMed     Text format    


  3. LOFFROY R, Bardou M
    Prophylactic angiographic embolisation in high-risk peptic ulcer bleeding after achieved endoscopic control: maximising outcomes.
    Gut. 2018 Jul 11. pii: gutjnl-2018-316925. doi: 10.1136/gutjnl-2018-316925.
    PubMed     Text format    


  4. POTTER MDE, Wood NK, Walker MM, Jones MP, et al
    Proton pump inhibitors and suppression of duodenal eosinophilia in functional dyspepsia.
    Gut. 2018 Jul 7. pii: gutjnl-2018-316878. doi: 10.1136/gutjnl-2018-316878.
    PubMed     Text format    


    June 2018
  5. KAWAI T, Oda K, Funao N, Nishimura A, et al
    Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study.
    Gut. 2018;67:1033-1041.
    PubMed     Text format     Abstract available


    May 2018
  6. KOBAYASHI J, Uchida H, Ito J
    Long-term proton pump inhibitor use after Helicobacter pylori eradication may create a gastric environment for N-nitrosamine formation and gastric cancer development.
    Gut. 2018 May 25. pii: gutjnl-2018-316592. doi: 10.1136/gutjnl-2018-316592.
    PubMed     Text format    


  7. LAU JYW, Pittayanon R, Wong KT, Pinjaroen N, et al
    Prophylactic angiographic embolisation after endoscopic control of bleeding to high-risk peptic ulcers: a randomised controlled trial.
    Gut. 2018 May 25. pii: gutjnl-2018-316074. doi: 10.1136/gutjnl-2018-316074.
    PubMed     Text format     Abstract available


    April 2018
  8. SUNG JJ, Chiu PC, Chan FKL, Lau JY, et al
    Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018.
    Gut. 2018 Apr 24. pii: gutjnl-2018-316276. doi: 10.1136/gutjnl-2018-316276.
    PubMed     Text format     Abstract available


  9. LAI SW, Lai HC, Lin CL, Liao KF, et al
    Proton pump inhibitors and risk of gastric cancer in a case-control study.
    Gut. 2018 Apr 16. pii: gutjnl-2018-316371. doi: 10.1136/gutjnl-2018-316371.
    PubMed     Text format    


  10. WAN QY, Wu XT, Li N, Du L, et al
    Long-term proton pump inhibitors use and risk of gastric cancer: a meta-analysis of 926 386 participants.
    Gut. 2018 Apr 3. pii: gutjnl-2018-316416. doi: 10.1136/gutjnl-2018-316416.
    PubMed     Text format    


    February 2018
  11. PENG YC, Huang LR, Lin CL, Hsu WY, et al
    Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD.
    Gut. 2018 Feb 22. pii: gutjnl-2018-316057. doi: 10.1136/gutjnl-2018-316057.
    PubMed     Text format    


    January 2018
  12. DOORAKKERS E, Lagergren J, Engstrand L, Brusselaers N, et al
    Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population.
    Gut. 2018 Jan 30. pii: gutjnl-2017-315363. doi: 10.1136/gutjnl-2017-315363.
    PubMed     Text format     Abstract available


  13. SUISSA S, Suissa A
    Proton-pump inhibitors and increased gastric cancer risk: time-related biases.
    Gut. 2018 Jan 3. pii: gutjnl-2017-315729. doi: 10.1136/gutjnl-2017-315729.
    PubMed     Text format    


    December 2017
  14. NIIKURA R, Hayakawa Y, Hirata Y, Yamada A, et al
    Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis.
    Gut. 2017 Dec 22. pii: gutjnl-2017-315710. doi: 10.1136/gutjnl-2017-315710.
    PubMed     Text format    


  15. SUZUKI H, Matsuzaki J
    Helicobacter pylori eradication failure may have confounded the recent large-scale health database study that showed proton pump inhibitors increase gastric cancer risk.
    Gut. 2017 Dec 15. pii: gutjnl-2017-315698. doi: 10.1136/gutjnl-2017-315698.
    PubMed     Text format    


    November 2017
  16. GUETA I, Halkin H, Markovits N, Loebstein R, et al
    Proton pump inhibitors and the risk for gastric cancer: possible confounding by serum vitamin B 12.
    Gut. 2017 Nov 28. pii: gutjnl-2017-315695. doi: 10.1136/gutjnl-2017-315695.
    PubMed     Text format    


  17. WALDUM HL, Fossmark R
    Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in man.
    Gut. 2017 Nov 20. pii: gutjnl-2017-315629. doi: 10.1136/gutjnl-2017-315629.
    PubMed     Text format    


    October 2017
  18. CHEUNG KS, Chan EW, Wong AYS, Chen L, et al
    Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study.
    Gut. 2017 Oct 31. pii: gutjnl-2017-314605. doi: 10.1136/gutjnl-2017-314605.
    PubMed     Text format     Abstract available


  19. REVELES KR, Ryan CN, Chan L, Cosimi RA, et al
    Proton pump inhibitor use associated with changes in gut microbiota composition.
    Gut. 2017 Oct 9. pii: gutjnl-2017-315306. doi: 10.1136/gutjnl-2017-315306.
    PubMed     Text format    


  20. MIZOKAMI Y, Oda K, Funao N, Nishimura A, et al
    Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study.
    Gut. 2017 Oct 7. pii: gutjnl-2017-314010. doi: 10.1136/gutjnl-2017-314010.
    PubMed     Text format     Abstract available


    September 2017
  21. GRAHAM DY
    Illusions regarding Helicobacter pylori clinical trials and treatment guidelines.
    Gut. 2017 Sep 21. pii: gutjnl-2017-314744. doi: 10.1136/gutjnl-2017-314744.
    PubMed     Text format    


  22. NOTO JM, Chopra A, Loh JT, Romero-Gallo J, et al
    Pan-genomic analyses identify key Helicobacter pylori pathogenic loci modified by carcinogenic host microenvironments.
    Gut. 2017 Sep 18. pii: gutjnl-2017-313863. doi: 10.1136/gutjnl-2017-313863.
    PubMed     Text format     Abstract available


  23. HUO X, Agoston AT, Dunbar KB, Cipher DJ, et al
    Hypoxia-inducible factor-2alpha plays a role in mediating oesophagitis in GORD.
    Gut. 2017;66:1542-1554.
    PubMed     Text format     Abstract available


    August 2017
  24. VOHLONEN IJ, Hakama M, Harkonen M, Malila N, et al
    Oesophageal cancer incidence in 20-year follow-up in a population-based sample of 12 000 middle-age men with or without Helicobacter pylori infection in Finland.
    Gut. 2017 Aug 31. pii: gutjnl-2017-314913. doi: 10.1136/gutjnl-2017-314913.
    PubMed     Text format    


    June 2017
  25. MERA RM, Bravo LE, Camargo MC, Bravo JC, et al
    Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial.
    Gut. 2017 Jun 24. pii: gutjnl-2016-311685. doi: 10.1136/gutjnl-2016-311685.
    PubMed     Text format     Abstract available


  26. LIN PY, Tang JH, Chang CC
    A rare cause of GI bleeding in a 56-year-old man.
    Gut. 2017;66:1074.
    PubMed     Text format    


    May 2017
  27. SIERRA JC, Asim M, Verriere TG, Piazuelo MB, et al
    Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis.
    Gut. 2017 May 4. pii: gutjnl-2016-312888. doi: 10.1136/gutjnl-2016-312888.
    PubMed     Text format     Abstract available


    April 2017
  28. HOUGHTON LA, Smith JA
    Gastro-oesophageal reflux events: just another trigger in chronic cough?
    Gut. 2017 Apr 25. pii: gutjnl-2017-314027. doi: 10.1136/gutjnl-2017-314027.
    PubMed     Text format    


  29. LORD AR, Simms LA, Hanigan K, Sullivan R, et al
    Protective effects of Helicobacter pylori for IBD are related to the cagA-positive strain.
    Gut. 2017 Apr 13. pii: gutjnl-2017-313805. doi: 10.1136/gutjnl-2017-313805.
    PubMed     Text format    


    February 2017
  30. EUSEBI LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, et al
    Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis.
    Gut. 2017 Feb 23. pii: gutjnl-2016-313589. doi: 10.1136/gutjnl-2016-313589.
    PubMed     Text format     Abstract available


    December 2016
  31. OTSUKA T, Sugimoto M, Inoue R, Ohno M, et al
    Influence of potassium-competitive acid blocker on the gut microbiome of Helicobacter pylori-negative healthy individuals.
    Gut. 2016 Dec 13. pii: gutjnl-2016-313312. doi: 10.1136/gutjnl-2016-313312.
    PubMed     Text format    


    October 2016
  32. MERCHANT JL
    NF-kappaB mediated transcription of DARPP-32 prevents Helicobacter pylori-induced cell death.
    Gut. 2016 Oct 27. pii: gutjnl-2016-312822. doi: 10.1136/gutjnl-2016-312822.
    PubMed     Text format    


  33. MALFERTHEINER P, Megraud F, O'Morain CA, Gisbert JP, et al
    Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
    Gut. 2016 Oct 5. pii: gutjnl-2016-312288. doi: 10.1136/gutjnl-2016-312288.
    PubMed     Text format     Abstract available


    September 2016
  34. YEO YH, Shiu SI, Ho HJ, Zou B, et al
    First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis.
    Gut. 2016 Sep 26. pii: gutjnl-2016-311868. doi: 10.1136/gutjnl-2016-311868.
    PubMed     Text format     Abstract available


  35. MOLINA-INFANTE J, Hirano I, Spechler SJ
    Clarifying misunderstandings and misinterpretations about proton pump inhibitor-responsive oesophageal eosinophilia.
    Gut. 2016 Sep 13. pii: gutjnl-2016-312851. doi: 10.1136/gutjnl-2016-312851.
    PubMed     Text format    


  36. ZHU S, Soutto M, Chen Z, Peng D, et al
    Helicobacter pylori-induced cell death is counteracted by NF-kappaB-mediated transcription of DARPP-32.
    Gut. 2016 Sep 2. pii: gutjnl-2016-312141. doi: 10.1136/gutjnl-2016-312141.
    PubMed     Text format     Abstract available


    July 2016
  37. MUIR AB, Wang ML, Metz D, Falk G, et al
    Proton pump inhibitor-responsive oesophageal eosinophilia: too early to change clinical practice.
    Gut. 2016 Jul 26. pii: gutjnl-2016-312601. doi: 10.1136/gutjnl-2016-312601.
    PubMed     Text format    


    June 2016
  38. FOCK KM, Talley N, Goh KL, Sugano K, et al
    Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus.
    Gut. 2016 Jun 3. pii: gutjnl-2016-311715. doi: 10.1136/gutjnl-2016-311715.
    PubMed     Text format     Abstract available


    May 2016
  39. KATAYAMA Y, Toyoda K, Kusano Y, Suda T, et al
    Efficacy of vonoprazan-based second-line Helicobacter pylori eradication therapy in patients for whom vonoprazan-based fi rst-line treatment failed.
    Gut. 2016 May 17. pii: gutjnl-2016-312028. doi: 10.1136/gutjnl-2016-312028.
    PubMed     Text format    


    April 2016
  40. MEJIAS-LUQUE R, Zoller J, Anderl F, Loew-Gil E, et al
    Lymphotoxin beta receptor signalling executes Helicobacter pylori-driven gastric inflammation in a T4SS-dependent manner.
    Gut. 2016 Apr 13. pii: gutjnl-2015-310783. doi: 10.1136/gutjnl-2015-310783.
    PubMed     Text format     Abstract available


  41. GRAHAM DY
    Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues.
    Gut. 2016 Apr 7. pii: gutjnl-2016-311796. doi: 10.1136/gutjnl-2016-311796.
    PubMed     Text format    


    March 2016
  42. MURAKAMI K, Sakurai Y, Shiino M, Funao N, et al
    Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study.
    Gut. 2016 Mar 2. pii: gutjnl-2015-311304. doi: 10.1136/gutjnl-2015-311304.
    PubMed     Text format     Abstract available


    February 2016
  43. DORE MP, Lu H, Graham DY
    Role of bismuth in improving Helicobacter pylori eradication with triple therapy.
    Gut. 2016 Feb 4. pii: gutjnl-2015-311019. doi: 10.1136/gutjnl-2015-311019.
    PubMed     Text format     Abstract available


    December 2015
  44. JACKSON MA, Goodrich JK, Maxan ME, Freedberg DE, et al
    Proton pump inhibitors alter the composition of the gut microbiota.
    Gut. 2015 Dec 30. pii: gutjnl-2015-310861. doi: 10.1136/gutjnl-2015-310861.
    PubMed     Text format     Abstract available


  45. MOLINA-INFANTE J, Bredenoord AJ, Cheng E, Dellon ES, et al
    Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis.
    Gut. 2015 Dec 18. pii: gutjnl-2015-310991. doi: 10.1136/gutjnl-2015-310991.
    PubMed     Text format     Abstract available


  46. IMHANN F, Bonder MJ, Vich Vila A, Fu J, et al
    Proton pump inhibitors affect the gut microbiome.
    Gut. 2015 Dec 9. pii: gutjnl-2015-310376. doi: 10.1136/gutjnl-2015-310376.
    PubMed     Text format     Abstract available


    September 2015
  47. LIOU JM, Chen CC, Chang CY, Chen MJ, et al
    Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial.
    Gut. 2015 Sep 3. pii: gutjnl-2015-310142. doi: 10.1136/gutjnl-2015-310142.
    PubMed     Text format     Abstract available


  48. ZHANG W, Chen Q, Liang X, Liu W, et al
    Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy.
    Gut. 2015 Sep 2. pii: gutjnl-2015-309900. doi: 10.1136/gutjnl-2015-309900.
    PubMed     Text format     Abstract available


    July 2015
  49. SUGANO K, Tack J, Kuipers EJ, Graham DY, et al
    Kyoto global consensus report on Helicobacter pylori gastritis.
    Gut. 2015 Jul 17. pii: gutjnl-2015-309252. doi: 10.1136/gutjnl-2015-309252.
    PubMed     Text format     Abstract available


    May 2015
  50. PAN KF, Zhang L, Gerhard M, Ma JL, et al
    A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication.
    Gut. 2015 May 18. pii: gutjnl-2015-309197. doi: 10.1136/gutjnl-2015-309197.
    PubMed     Text format     Abstract available


  51. WANG XY, Dai YH, Yang YM
    Unusual cause of a giant antral ulcer.
    Gut. 2015;64:730.
    PubMed     Text format    


    April 2015
  52. NG GZ, Menheniott TR, Every AL, Stent A, et al
    The MUC1 mucin protects against Helicobacter pylori pathogenesis in mice by regulation of the NLRP3 inflammasome.
    Gut. 2015 Apr 8. pii: gutjnl-2014-307175. doi: 10.1136/gutjnl-2014-307175.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: